Author:
Dancey J.E.,Dodd L.E.,Ford R.,Kaplan R.,Mooney M.,Rubinstein L.,Schwartz L.H.,Shankar L.,Therasse P.
Reference13 articles.
1. Progression-free survival is a surrogate for survival in advanced colorectal cancer;Buyse;J Clin Oncol,2007
2. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer;Burzykowski;J Clin Oncol,2008
3. US Department of Health and Human Services FaDA. Guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics. ; 2007 [accessed 19.08.08].
4. (CHMP) CfMPfHU. Guideline on the evaluation of anticancer medicinal products in man. European Medicines Agency 7 Westferry Circus, Canary Wharf, London E14 4HB, UK; 2005.
5. Individual patient data analysis to assess modifications to the RECIST criteria;Bogaerts;Eur J Cancer,2009
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献